Leslie Benson

Publications

1. Distinct plasma lipids predict axonal injury and multiple sclerosis activity. J Neurol Neurosurg Psychiatry. 2025 Jan 16; 96(2):150-157. View Abstract
2. Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024 Dec 16; 96(1):68-75. View Abstract
3. Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology. 2024 Dec 10; 103(11):e209991. View Abstract
4. Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis. Mult Scler. 2024 Oct; 30(11-12):1525-1543. View Abstract
5. Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurol Neuroimmunol Neuroinflamm. 2024 Sep; 11(5):e200282. View Abstract
6. Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Mult Scler. 2024 Jul; 30(8):1056-1065. View Abstract
7. Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Mult Scler Relat Disord. 2024 Jul; 87:105647. View Abstract
8. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315. View Abstract
9. Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Mult Scler Relat Disord. 2024 Feb; 82:105351. View Abstract
10. Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. Ann Clin Transl Neurol. 2024 01; 11(1):169-184. View Abstract
11. Characteristics and predictors of disease course in children initially presenting with ADEM. Mult Scler Relat Disord. 2023 Oct 15; 80:105075. View Abstract
12. Disease modifying treatment for pediatric onset multiple sclerosis: Ethical considerations and strategies to navigate parental refusal. Mult Scler Relat Disord. 2023 11; 79:104970. View Abstract
13. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): a collaborative review of the current understanding. Clin Auton Res. 2023 06; 33(3):251-268. View Abstract
14. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 Aug; 145:125-131. View Abstract
15. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 04; 29(4-5):576-584. View Abstract
16. Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. Mult Scler Relat Disord. 2023 Mar; 71:104573. View Abstract
17. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry. 2023 07; 94(7):518-525. View Abstract
18. Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 02 28; 100(9):e985-e994. View Abstract
19. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 02; 93(2):271-284. View Abstract
20. A new look at cognitive functioning in pediatric MS. Mult Scler. 2023 01; 29(1):140-149. View Abstract
21. Challenges in the Clinical Recognition of Acute Flaccid Myelitis and its Implications. J Pediatr. 2023 02; 253:55-62.e4. View Abstract
22. Evaluation of white matter microstructure in pediatric onset multiple sclerosis with diffusion compartment imaging. J Neuroimaging. 2022 11; 32(6):1098-1108. View Abstract
23. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. J Rheumatol. 2022 Sep; 49(9):1042-1051. View Abstract
24. ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD. Ann Neurol. 2022 08; 92(2):279-291. View Abstract
25. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Mult Scler. 2022 08; 28(9):1330-1339. View Abstract
26. Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology. 2022 01 18; 98(3):e267-e278. View Abstract
27. Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis. J Neuroophthalmol. 2021 12 01; 41(4):469-475. View Abstract
28. Child Neurology: Recurrent Brainstem Strokes and Aphthous Ulcers in a Child With Mutations in the ADA2 Gene. Neurology. 2021 Oct 04; 97(14):696-699. View Abstract
29. Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med. 2021 Oct; 27(10):1849. View Abstract
30. Gut microbiome is associated with multiple sclerosis activity in children. Ann Clin Transl Neurol. 2021 09; 8(9):1867-1883. View Abstract
31. Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5). View Abstract
32. Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population. J Neuroophthalmol. 2021 03 01; 41(1):19-23. View Abstract
33. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021 01 23; 397(10271):334-346. View Abstract
34. Acute Flaccid Myelitis: A Call for Vigilance and an Update on Management. Pediatr Neurol. 2021 01; 114:26-28. View Abstract
35. Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain. 2020 09 01; 143(9):2733-2741. View Abstract
36. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology. 2020 09 29; 95(13):e1844-e1853. View Abstract
37. Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol. 2020 07; 88(1):42-55. View Abstract
38. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler. 2020 12; 26(14):1938-1947. View Abstract
39. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med. 2019 11; 25(11):1748-1752. View Abstract
40. Unmet Needs in the Evaluation, Treatment, and Recovery for 167 Children Affected by Acute Flaccid Myelitis Reported by Parents Through Social Media. Pediatr Neurol. 2020 01; 102:20-27. View Abstract
41. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol. 2019 Jun; 6(6):1053-1061. View Abstract
42. Vitamin D genes influence MS relapses in children. Mult Scler. 2020 07; 26(8):894-901. View Abstract
43. Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. Neurol Neuroimmunol Neuroinflamm. 2019 05; 6(3):e560. View Abstract
44. Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. Blood Adv. 2019 02 26; 3(4):503-507. View Abstract
45. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019 Feb 14; 17(1):7. View Abstract
46. Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016. JAMA Pediatr. 2019 02 01; 173(2):134-139. View Abstract
47. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 2019 01; 15(1):e1007808. View Abstract
48. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol. 2019 03; 34(3):148-152. View Abstract
49. Magnetic resonance imaging in enterovirus-71, myelin oligodendrocyte glycoprotein antibody, aquaporin-4 antibody, and multiple sclerosis-associated myelitis in children. Dev Med Child Neurol. 2019 09; 61(9):1108-1116. View Abstract
50. Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. J Neuropathol Exp Neurol. 2018 12 01; 77(12):1079-1084. View Abstract
51. Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology. 2019 04 30; 92(18):e2118-e2126. View Abstract
52. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology. 2018 11 06; 91(19):e1778-e1787. View Abstract
53. Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Ann Clin Transl Neurol. 2018 Dec; 5(12):1513-1521. View Abstract
54. Urban air quality and associations with pediatric multiple sclerosis. Ann Clin Transl Neurol. 2018 Oct; 5(10):1146-1153. View Abstract
55. Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol. 2018 Oct; 5(10):1222-1228. View Abstract
56. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2018 May; 22:103-107. View Abstract
57. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):28-33. View Abstract
58. Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2018 12; 24(14):1825-1834. View Abstract
59. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169. View Abstract
60. Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler. 2018 07; 24(8):1067-1076. View Abstract
61. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017 Apr 25; 88(17):1623-1629. View Abstract
62. Investigations in GABAA receptor antibody-associated encephalitis. Neurology. 2017 Mar 14; 88(11):1012-1020. View Abstract
63. Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Ann Clin Transl Neurol. 2016 12; 3(12):897-907. View Abstract
64. Pediatric optic neuritis. Neurology. 2016 Aug 30; 87(9 Suppl 2):S53-8. View Abstract
65. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics. 2016 07; 138(1). View Abstract
66. Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016 12; 87(12):1350-1353. View Abstract
67. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2016 Mar; 6:87-92. View Abstract
68. Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2016 Feb; 3(1):e188. View Abstract
69. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016 Jan 19; 86(3):245-52. View Abstract
70. Pain and spinal cord imaging measures in children with demyelinating disease. Neuroimage Clin. 2015; 9:338-47. View Abstract
71. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016 Apr; 22(4):470-82. View Abstract
72. Reply: To PMID 24907434. Am J Ophthalmol. 2015 Jan; 159(1):211. View Abstract
73. Evaluation and treatment of autoimmune neurologic disorders in the pediatric intensive care unit. Semin Pediatr Neurol. 2014 Dec; 21(4):284-90. View Abstract
74. The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol. 2015 Sep; 30(10):1381-7. View Abstract
75. Visual outcomes in pediatric optic neuritis. Am J Ophthalmol. 2014 Sep; 158(3):503-7.e2. View Abstract
76. Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis. Neurology. 2014 Jun 17; 82(24):2173-9. View Abstract
77. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014 Mar; 75(3):411-28. View Abstract
78. Functional relapses in pediatric multiple sclerosis. J Child Neurol. 2014 Jul; 29(7):943-6. View Abstract
79. Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Mult Scler Relat Disord. 2014 Mar; 3(2):186-93. View Abstract
80. New onset epilepsy in Prader-Willi syndrome: semiology and literature review. Pediatr Neurol. 2010 Oct; 43(4):297-9. View Abstract
81. Characterization of selected elementary motion detector cells to image primitives. Biomed Sci Instrum. 2008; 44:410-6. View Abstract
Show All Publications Show Fewer Publications